Company
MAIA Biotechnology, Inc. (MAIA)
Standardized SEC financial data for MAIA Biotechnology, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001878313 · NYSE · Pharmaceutical Preparations.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | — |
| R&D expense | $3.5M | $8.9M | $11.1M | $10.0M | $14.5M |
| SG&A expense | $4.3M | $6.1M | $9.1M | $6.9M |
Standardized from MAIA Biotechnology, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $663K | $10.6M | $11.0M | $7.2M | $9.6M | $0 |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.1M | -$12.1M | -$13.1M | -$15.7M | -$18.8M |
| Financing cash flow | $14.0M | $12.5M |
Get MAIA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MAIA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MAIA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"